Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 19,000 shares at $45.73 ($869K) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Open-market sale of $869k CRNX by Chief Med and Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.73 | 9,500 | $434K | 50.0% |
| 2 | $45.73 | 9,500 | $434K | 50.0% |
| Total | $45.73 avg | 19,000 | $869K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |